Results 231 to 240 of about 58,549 (319)

Screening Yield of Inherited Bleeding Disorder Questionnaires in Women With Chronic Heavy Menstrual Bleeding (HMB): A Cross-Sectional Study. [PDF]

Cureus
Faiz A, Dawelbait Radwan ME, Iqbal S, Vinayak S, Gowda D, Mani Tripathi K, Mahmood GM, Akbar H, Kanwal M, Sunil A, Al Niazi R, Naeem A.   +11 more
europepmc   +1 more source

Ascitic fluid concentrations of fibronectin and cholesterol [PDF]

, 1990
Gerbes, Alexander L., Jüngst, Dieter, Mezger, J., Xie, Yining   +3 more
core  

Staphylococcus lugdunensis‐Infected Left Atrial Myxoma Complicated by Mitral Valve Endocarditis and Septic Emboli: A Case Report

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Cardiac myxomas are benign tumors; however, infected myxomas represent a rare clinical presentation. Infected myxomas can cause concomitant infective valve endocarditis, which may lead to complications such as persistent bacteremia, valvular insufficiency/stenosis, and embolic phenomena if not treated promptly.
Karuna Rayamajhi, Fnu Parul, Zan Siddiqi, Majid Yavari, Michael J. Kehdi, Subhashis Mitra   +5 more
wiley   +1 more source

A 4-Week-Old Female Infant with Type 3 von Willebrand Disease Presenting with Nosebleeds and Uncontrolled Bleeding Following Surgical Frenectomy: A Clinical Case. [PDF]

Am J Case Rep
Zima A, Iwaniec T, Zdziarska J, Sacha T, Żuber Z.   +4 more
europepmc   +1 more source

Refractory Acquired von Willebrand Disease Despite Successful Treatment of the Associated Lymphoma [PDF]

, 2002
Wendy Slattery, Douglas J. Rausch, Nabil F. Saba   +2 more
openalex   +1 more source

Use of PopPK and E‐R Analyses toward Explaining Causal Link Between ADAMTS13 in Recombinant vs. Plasma‐Based Therapies and Clinical Effects in cTTP

Clinical Pharmacology &Therapeutics, Volume 118, Issue 4, Page 813-822, October 2025.
Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultra‐rare, potentially life‐threatening condition caused by a deficiency of the blood enzyme ADAMTS13. Until now, ADAMTS13 replacement has been achieved with infusions of plasma or plasma‐based therapies (PBT).
Munjal Patel, Huijuan Xu, Olivier Barriere, Paul Diderichsen, Parth Patwari, Andy Z. X. Zhu, Jean François Marier, Thomas Peyret, Linda T. Wang, Björn Mellgård, Wenping Wang, Indranil Bhattacharya   +11 more
wiley   +1 more source

Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational study. [PDF]

Rheumatol Int
Jud P, Douschan P, Sassmann T, Silbernagel G, Gütl K, Raggam RB, Rief P, Schweiger L, John N, Seinost G, Foris V, Kovacs G, Gary T, Nemecz V, Meinitzer A, Strohmaier H, Odler B, Moazedi-Fürst F, Brodmann M, Hafner F.   +19 more
europepmc   +1 more source

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study [PDF]

, 2002
Pier Mannuccio Mannucci, Juan Chediak, Wahid T. Hanna, John Byrnes, Marlies Ledford, Bruce M. Ewenstein, Anastassios D. Retzios, Barbara Kapelan, Richard S. Schwartz, Craig M. Kessler   +9 more
openalex   +1 more source

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease. [PDF]

Res Pract Thromb Haemost
El Otmani H, Stamouli M, Adelmeijer J, Bernal W, Maas C, Patel VC, Lisman T.   +6 more
europepmc   +1 more source

The Association of Elevated Factor VIII and von Willebrand Factor (vWF) Levels with SYNTAX Score in Patients with Chronic Coronary Syndrome. [PDF]

Biomedicines
Djuric P, Mladenovic Z, Jovic Z, Vukotic S, Spasic M, Mijuskovic M, Terzic B, Radojicic Z, Radisavljevic N, Djuric M, Djuric D.   +10 more
europepmc   +1 more source